TransCode Therapeutics (RNAZ) Stock Chart & Stock Price History $10.39 -0.26 (-2.44%) Closing price 04:00 PM EasternExtended Trading$10.04 -0.35 (-3.32%) As of 05:39 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock TransCode Therapeutics Stock Price Performance The TransCode Therapeutics (RNAZ) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 99.87%, with a year-to-date return of -88.99%. In the past month, the stock has increased 12.32%, reflecting recent market activity. As of the latest close, TransCode Therapeutics traded at $10.65 with a market cap of $8.84 million and volume of 26,291 shares. Receive RNAZ Stock News and Ratings via EmailSign-up to receive the latest news and ratings for TransCode Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-9.65%1 Month Performance+12.32%3 Month Performance+5.72%Year-To-Date Performance-88.99%1 Year Performance-99.87% RNAZ Stock Chart for Friday, August, 8, 2025 RNAZ Chart by TradingView TransCode Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/07/2025$11.11$10.65-4.14%$11.43$10.5026,291 shs$8.84 million08/06/2025$11.50$11.11-3.39%$11.70$10.9020,170 shs$9.22 million08/05/2025$11.40$11.50+0.88%$12.10$11.3717,298 shs$9.59 million08/04/2025$11.50$11.40-0.87%$11.64$10.7641,993 shs$9.46 million08/01/2025$11.10$11.50+3.60%$12.22$10.1736,609 shs$9.55 million07/31/2025$11.15$11.10-0.45%$11.59$10.8414,153 shs$9.21 million07/30/2025$11.76$11.15-5.19%$11.89$11.0026,528 shs$9.25 million07/29/2025$13.89$11.76-15.33%$13.99$11.5078,766 shs$9.76 million07/28/2025$11.74$13.89+18.31%$15.88$11.18196,097 shs$11.53 million07/25/2025$11.00$11.74+6.73%$11.83$10.2866,051 shs$9.74 million Get the Latest News and Ratings for RNAZ and Related StocksEnter your email address below to receive the latest news and analysts' ratings for TransCode Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 07/24/2025$11.27$11.00-2.40%$12.43$10.80148,783 shs$9.13 million07/23/2025$9.44$11.27+19.39%$17.24$10.974.16 million shs$9.40 million07/22/2025$9.69$9.44-2.58%$9.90$9.3915,701 shs$7.84 million07/21/2025$9.94$9.69-2.52%$9.90$9.3811,511 shs$8.04 million07/18/2025$10.05$9.94-1.09%$10.38$9.0235,542 shs$8.25 million07/17/2025$9.38$10.05+7.14%$10.30$9.1333,918 shs$8.37 million07/16/2025$8.72$9.38+7.57%$9.44$8.7832,231 shs$7.79 million07/15/2025$9.11$8.72-4.28%$8.92$8.6511,494 shs$7.26 million07/14/2025$8.69$9.11+4.83%$9.15$8.2814,129 shs$7.59 million07/11/2025$9.00$8.69-3.44%$8.91$8.5019,887 shs$7.24 million07/10/2025$9.13$9.00-1.42%$9.34$8.7829,557 shs$7.47 million07/09/2025$9.25$9.13-1.30%$9.52$9.0027,741 shs$7.58 million07/08/2025$8.05$9.25+14.91%$9.70$8.0444,668 shs$7.71 million07/07/2025$8.04$8.05+0.12%$8.61$8.0513,003 shs$6.68 million Related Companies Coeptis Therapeutics Stock Chart LAVA Therapeutics Stock Chart Sol-Gel Technologies Stock Chart Ovid Therapeutics Stock Chart Shattuck Labs Stock Chart Medicus Pharma Stock Chart Enlivex Therapeutics Stock Chart Karyopharm Therapeutics Stock Chart Xilio Therapeutics Stock Chart Rani Therapeutics Stock Chart Receive RNAZ Stock News and Ratings via EmailSign-up to receive the latest news and ratings for TransCode Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:RNAZ) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredCrypto bros: Meet your replacementLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredFormer CIA Officer Reveals How Gold Saved His Life This isn’t just another gold investing book—it’s a survival playbook written by a former CIA officer trained...Advantage Gold | SponsoredHow high will gold surge?Weiss Gold Veteran Makes Shocking New Call Weiss expert Sean Brodrick went out on a limb last year and decl...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TransCode Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share TransCode Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
